Stockreport

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

ENZON PHARMS INC  (ENZN) 
US:NASDAQ Investor Relations: investor.enzon.com/investor-relations
PDF CRANFORD, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) today announced that it has extended the expirat [Read more]